SCHEMBL6838677

SCHEMBL6838677

FC(F)(F)c1nc2ccccc2c2c1nc(-c1ccco1)n2CCC1CCNCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASR P41180 1/20 0.40
ALDH1A1 P00352 10/20 0.39
SMN1; SMN2 Q16637 6/20 0.39
TSHR P16473 5/20 0.39
LMNA P02545 3/20 0.39
PKM P14618 1/20 0.39
HSD17B10 Q99714 7/20 0.36
KDM4E B2RXH2 7/20 0.36
HPGD P15428 5/20 0.36
POLB P06746 2/20 0.36
NPY1R P25929 1/20 0.35
TP53 P04637 2/20 0.35
USP2 O75604 5/20 0.35
ALOX15 P16050 4/20 0.35
GLA P06280 3/20 0.35
GAA P10253 3/20 0.35
CASP1 P29466 3/20 0.35
CASP7 P55210 3/20 0.35
MEN1 O00255 1/20 0.35
HBB P68871 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6840136 0.90 CCR3 (0.33) CASRALDH1A1TSHRHSD17B10KDM4E
SCHEMBL6838074 0.90 ALDH1A1 (0.33) CASRALDH1A1SMN1; SMN2TSHRPKM
SCHEMBL6837741 0.89 NPY1R (0.37) ALDH1A1SMN1; SMN2TSHRLMNAPKM
SCHEMBL6927485 0.88 ALDH1A1 (0.43) CASRALDH1A1SMN1; SMN2TSHRLMNA
SCHEMBL6838630 0.88 NPY1R (0.35) CASRALDH1A1SMN1; SMN2TSHRLMNA
SCHEMBL6928340 0.87 ALDH1A1 (0.42) CASRALDH1A1SMN1; SMN2TSHRLMNA
SCHEMBL6833713 0.87 NPY1R (0.39) CASRNPY1RTLR7HTR4
SCHEMBL6833751 0.83 ACP1 (0.38) POLBNPY1RMEN1KMT2ATLR7
SCHEMBL6838577 0.83 PDE6D (0.37) ALDH1A1SMN1; SMN2KDM4EHPGDPOLB
SCHEMBL6840049 0.83 ALDH1A1 (0.38) ALDH1A1KDM4EHPGDPOLBNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040054182-A1 1h-imidazopyridine derivatives HOKURIKU SEIYAKU CO., LTD. (JP) 2004-03-18 US disclosed
EP-1256582-A1 1H-IMIDAZOPYRIDINE DERIVATIVES HOKURIKU SEIYAKU CO., LTD. (JP) 2002-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040054182-A1 1h-imidazopyridine derivatives IL2, IL1A, IL4 CASR 2571/4885ALDH1A1 504/4885SMN1; SMN2 4053/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.